The study of killing effect and inducing apoptosis of 630-nm laser on lung adenocarcinoma A549 cells mediated by hematoporphyrin derivatives in vitro

  • Cunzhi Lin
  • Yuanyuan Zhang
  • Xinhong Zhu
  • Shichao Cui
  • Yiwei Cao
  • Rong Li
  • Lijun WangEmail author
Original Article


To investigate the killing effect and inducing apoptosis of 630-nm laser mediated by hematoporphyrin derivatives (HPD) on human lung adenocarcinoma A549 cells. The human lung adenocarcinoma A549 cells were incubated at random with different concentrations of HPD (5, 10, 12, 15, 20 μg/ml) for 4 h and then illuminated by 630-nm laser with different energy densities (25, 50, 75, 100 mW/cm2). And, meanwhile, the simple photosensitizer group, laser irradiation group, and blank control group were established. Then, CCK8, Hoechst 33258 staining, RT-PCR, and Western blot were employed. HPD-PDT proved no killing effect on the lung adenocarcinoma A549 cells with photosensitizer or laser irradiation alone. With the combination, the killing effect was obvious. CCK8 showed that the A549 cell viability in 15 μg/ml and 20 μg/ml HPD group as well as 50 mW/cm2, 75 mW/cm2, and 100 mW/cm2 power density group decreased significantly compared with the control group. Hoechst 33258 staining showed that with the increase of HPD concentration, the cells presented chromatin fixation and hyperchromatic nuclei. The Annexin V-FITC/PI double staining was used to detect the apoptosis rate, and the difference was statistically significant. RT-PCR and Western blot showed that the expression of Caspase-3 and Bax were significantly up-regulated. However, the Bcl-2 and Survivin were significantly down-regulated in the HPD-PDT group, while those of the other three groups showed no significant changes. HPD-PDT has a significant effect on A549 cells. The mechanism of action may be related to the upregulation of the expression of Caspase-3, Bax, and downregulation of the expression of Bcl-2 and Survivin.


Photodynamic therapy Hematoporphyrin derivative A549 cells Apoptosis Gene expression 


Funding information

This work was supported by the grants from Huangdao Science and Technology Bureau Project of Qingdao (2014-1-77).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies were in accordance with the ethical standards of the institution or practice at which the studies were conducted.


  1. 1.
    Ji HT et al (2010) 5-ALA mediated photodynamic therapy induces autophagic cell death via AMP-activated protein kinase. Mol Cancer 9(1):91CrossRefGoogle Scholar
  2. 2.
    Chen W et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115–132CrossRefGoogle Scholar
  3. 3.
    Kim KH, Park JJ (2010) The effects of photodynamic therapy in upper-gastrointestinal malignant diseases. Gut Liver 4 Suppl 1(4 Suppl 1):S39CrossRefGoogle Scholar
  4. 4.
    Dougherty TJ et al (1992) Photodynamic therapy. J Natl Cancer Inst 28(10):1734–1742Google Scholar
  5. 5.
    Agarwal ML et al (1991) Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res 51(21):5993–5996Google Scholar
  6. 6.
    Katrin Agnes S, Wood GS (2015) Epigenetically enhanced photodynamic therapy (ePDT) is superior to conventional photodynamic therapy for inducing apoptosis in cutaneous T-cell lymphoma. Photochem Photobiol 91(6):1444–1451CrossRefGoogle Scholar
  7. 7.
    Dougherty TJ (2002) An update on photodynamic therapy applications. J Clin Laser Med Surg 20(1):3CrossRefGoogle Scholar
  8. 8.
    Wozniak M et al (2018) The effect of in vitro photodynamic therapy on increase of osteopontin and heat shock protein 70 expression in squamous cell and colon carcinoma. IEEE J Sel Top Quantum Electron 25(1):1Google Scholar
  9. 9.
    Hung-Pin L et al (2010) Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia. J Oral Pathol Med 39(8):624–630CrossRefGoogle Scholar
  10. 10.
    Maloth KN et al (2016) Photodynamic therapy - a non-invasive treatment modality for precancerous lesions. J Lasers Med Sci 7(1):30CrossRefGoogle Scholar
  11. 11.
    Okunaka T et al (2004) Photodynamic therapy for peripheral lung cancer. Lung Cancer 43(1):77–82CrossRefGoogle Scholar
  12. 12.
    Zhang J et al (2018) An updated overview on the development of new photosensitizers for anticancer photodynamic therapy. Acta Pharm Sin B 8(2):137–146CrossRefGoogle Scholar
  13. 13.
    Zhang G, Zhang D (2018) New photosensitizer design concept: polymerization-enhanced photosensitization. Chem 4(9):2013–2015CrossRefGoogle Scholar
  14. 14.
    Choudhary S, Nouri K, Elsaie ML (2009) Photodynamic therapy in dermatology: a review. Lasers Med Sci 24(6):971–980CrossRefGoogle Scholar
  15. 15.
    Ujiie H et al (2019) Porphyrin-high-density lipoprotein: a novel photosensitizing nanoparticle for lung Cancer therapy. Ann Thorac Surg 107(2):369–377CrossRefGoogle Scholar
  16. 16.
    Agostinis P et al (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61(4):250–281CrossRefGoogle Scholar
  17. 17.
    Wang Y et al (2015) A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer. J Cancer Res Clin Oncol 142(4):813–821CrossRefGoogle Scholar
  18. 18.
    Burlacu A (2003) Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7(3):249–257CrossRefGoogle Scholar
  19. 19.
    Soriano ME, Scorrano L (2010) The interplay between BCL-2 family proteins and mitochondrial morphology in the regulation of apoptosis. Adv Exp Med Biol 687:97–114Google Scholar
  20. 20.
    Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116(2):205–219CrossRefGoogle Scholar
  21. 21.
    Lalier L et al (2007) Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12(5):887CrossRefGoogle Scholar
  22. 22.
    Martinou J-C, Youle R (2011) Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21(1):92–101CrossRefGoogle Scholar
  23. 23.
    SJ R, Y S (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5(11):897–907CrossRefGoogle Scholar
  24. 24.
    Vittar NBR et al (2010) Caspase-independent apoptosis, in human MCF-7c3 breast cancer cells, following photodynamic therapy, with a novel water-soluble phthalocyanine. Int J Biochem Cell Biol 42(7):1123–1131CrossRefGoogle Scholar
  25. 25.
    Sandy Wan-Heng H et al (2012) Photodynamic therapy of Pheophorbide a inhibits the proliferation of human breast tumour via both caspase-dependent and -independent apoptotic pathways in in vitro and in vivo models. Phytother Res 26(5):734–742CrossRefGoogle Scholar
  26. 26.
    Lončarevič-Vasiljkovič N et al (2016) Dietary restriction suppresses apoptotic cell death, promotes Bcl-2 and Bcl-xl mRNA expression and increases the Bcl-2/Bax protein ratio in the rat cortex after cortical injury. Neurochem Int 96:69–76CrossRefGoogle Scholar
  27. 27.
    Karczmarek-Borowska B et al (2005) Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study. Folia Histochem Cytobiol 43(4):237Google Scholar
  28. 28.
    Chen M et al (2017) Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis. Oncol Lett 13(1):370CrossRefGoogle Scholar
  29. 29.
    LF T et al (2011) Apoptosis in glioma cells treated with PDT. Photomed Laser Surg 29(5):305–309CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2019

Authors and Affiliations

  • Cunzhi Lin
    • 1
  • Yuanyuan Zhang
    • 1
  • Xinhong Zhu
    • 2
  • Shichao Cui
    • 1
  • Yiwei Cao
    • 1
  • Rong Li
    • 1
  • Lijun Wang
    • 2
    Email author
  1. 1.Department of RespirationThe Affiliated Hospital of Qingdao UniversityQingdaoChina
  2. 2.Department of Internal MedicineQingdao Municipal HospitalQingdaoChina

Personalised recommendations